References
1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al.
Global cancer Observatory: cancer today. Lyon, France: international
agency for research on cancer. 2018.
2. Sun Z, Sun X, Chen Z, Du J, Wu Y. Head and neck squamous cell
carcinoma: risk factors, molecular alterations, immunology and peptide
vaccines. International Journal of Peptide Research and Therapeutics.
2022;28:1-18.
3. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of
head and neck cancer. Nature reviews cancer. 2011;11(1):9-22.
4. Zhang Q, Wang H, Zhao Q, Zhang Y, Zheng Z, Liu S, et al. Evaluation
of risk factors for laryngeal squamous cell carcinoma: a single-center
retrospective study. Frontiers in oncology. 2021;11:606010.
5. Almadori G, Bussu F, Paludetti G. Predictive factors of neck
metastases in laryngeal squamous cell carcinoma. Towards an integrated
clinico-molecular classification. Acta otorhinolaryngologica italica.
2006;26(6):326.
6. Mariani P, Russo D, Maisto M, Troiano G, Caponio VCA, Annunziata M,
et al. Pre‐treatment neutrophil‐to‐lymphocyte ratio is an independent
prognostic factor in head and neck squamous cell carcinoma:
meta‐analysis and trial sequential analysis. Journal of Oral Pathology
& Medicine. 2022;51(1):39-51.
7. Rodrigo JP, Sánchez-Canteli M, López F, Wolf GT, Hernández-Prera JC,
Williams MD, et al. Tumor-infiltrating lymphocytes in the tumor
microenvironment of laryngeal squamous cell carcinoma: systematic review
and meta-analysis. Biomedicines. 2021;9(5):486.
8. Xu B, Salama AM, Valero C, Yuan A, Khimraj A, Saliba M, et al. The
prognostic role of histologic grade, worst pattern of invasion, and
tumor budding in early oral tongue squamous cell carcinoma: a
comparative study. Virchows Archiv. 2021:1-10.
9. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor
budding: the name is EMT. Partial EMT. Journal of clinical medicine.
2016;5(5):51.
10. Xue C, Du Y, Li Y, Xu H, Zhu Z. Tumor budding as a predictor for
prognosis and therapeutic response in gastric cancer: A mini review.
Frontiers in Oncology. 2023;12:1003959.
11. Voutsadakis IA. Prognostic role of tumor budding in breast cancer.
World journal of experimental medicine. 2018;8(2):12.
12. Boxberg M, Kuhn P-H, Reiser M, Erb A, Steiger K, Pickhard A, et al.
Tumor budding and cell nest size are highly prognostic in laryngeal and
hypopharyngeal squamous cell carcinoma. The American journal of surgical
pathology. 2019;43(3):303-13.
13. Kadota K, Nitadori J-i, Woo KM, Sima CS, Finley DJ, Rusch VW, et al.
Comprehensive pathological analyses in lung squamous cell carcinoma:
single cell invasion, nuclear diameter, and tumor budding are
independent prognostic factors for worse outcomes. Journal of Thoracic
Oncology. 2014;9(8):1126-39.
14. Karpathiou G, Vieville M, Gavid M, Camy F, Dumollard JM, Magné N, et
al. Prognostic significance of tumor budding, tumor‐stroma ratio, cell
nests size, and stroma type in laryngeal and pharyngeal squamous cell
carcinomas. Head & neck. 2019;41(6):1918-27.
15. Paşaoğlu HE, Emre F, Ege TŞ, Tetikkurt ÜS. High tumor budding
activity may predict poor prognosis in laryngeal squamous cell
carcinomas. Indian Journal of Pathology and Microbiology.
2022;65(2):280.
16. Luo L, Liu H. High-grade tumor budding is a risk factor for survival
in patients with laryngeal squamous cell carcinoma. Brazilian Journal of
Otorhinolaryngology. 2023:101310.
17. Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal
cancer. JAMA Otolaryngology–Head & Neck Surgery. 2014;140(9):855-60.
18. Choi N, Kim J, Yi H, Kim H, Kim TH, Chung MJ, et al. The use of
artificial intelligence models to predict survival in patients with
laryngeal squamous cell carcinoma. Scientific Reports. 2023;13(1):9734.
19. Zhu X, Duan F, Zhu Y, Shi X, Sun S, Cheng Y, et al. Perineural
Invasion as a Prognostic Factor in Laryngeal Squamous Cell Cancer: A
Matched-Pair Survival Analysis. Cancer Investigation. 2021;39(9):734-40.
20. Contrera KJ, Hair BB, Prendes B, Reddy CA, Zimmer DI, Burkey BB, et
al. Clinical versus pathologic laryngeal cancer staging and the impact
of stage change on outcomes. The Laryngoscope. 2021;131(3):559-65.
21. Bhat GR, Hyole RG, Li J. Chapter Two - Head and neck cancer: Current
challenges and future perspectives. In: Tew KD, Fisher PB, editors.
Advances in Cancer Research. 152: Academic Press; 2021. p. 67-102.
22. Weichert W, Kossakowski C, Harms A, Schirmacher P, Muley T,
Dienemann H, et al. Proposal of a prognostically relevant grading scheme
for pulmonary squamous cell carcinoma. European Respiratory Journal.
2016;47(3):938-46.
23. Leite CF, Silva KDd, Horta MCR, de Aguiar MCF. Can morphological
features evaluated in oral cancer biopsies influence in decision-making?
A preliminary study. Pathology - Research and Practice.
2020;216(10):153138.
24. Togni L, Caponio VCA, Zerman N, Troiano G, Zhurakivska K, Lo Muzio
L, et al. The Emerging Impact of Tumor Budding in Oral Squamous Cell
Carcinoma: Main Issues and Clinical Relevance of a New Prognostic
Marker. Cancers. 2022;14(15):3571.
25. Chiesa-Estomba CM, Thompson L, Agaimy A, Zidar N, Simpson RHW,
Franchi A, et al. Predictive value of tumor budding in head and neck
squamous cell carcinoma: an update. Virchows Archiv. 2023.
26. Melanie B, Christine B, Korinna J, Peer-Hendrik K, Bernhard H, Katja
S, et al. Novel prognostic histopathological grading system in oral
squamous cell carcinoma based on tumour budding and cell nest size shows
high interobserver and intraobserver concordance. Journal of Clinical
Pathology. 2019;72(4):285.
27. Mäkitie AA, Almangush A, Rodrigo JP, Ferlito A, Leivo I. Hallmarks
of cancer: Tumor budding as a sign of invasion and metastasis in head
and neck cancer. Head & neck. 2019;41(10):3712-8.
28. Jesinghaus M, Boxberg M, Konukiewitz B, Slotta-Huspenina J,
Schlitter AM, Steiger K, et al. A novel grading system based on tumor
budding and cell nest size is a strong predictor of patient outcome in
esophageal squamous cell carcinoma. The American journal of surgical
pathology. 2017;41(8):1112-20.
29. Ekmekci S, Kucuk U, Kokkoz S, Cakir E, Gumussoy M. Tumor budding in
laryngeal carcinoma. Indian J Pathol Microbiol. 2019;62(1):7-10.
30. Bjerkli I-H, Laurvik H, Nginamau ES, Søland TM, Costea D, Hov H, et
al. Tumor budding score predicts lymph node status in oral tongue
squamous cell carcinoma and should be included in the pathology report.
PLoS One. 2020;15(9):e0239783.
31. Abd Raboh NM, Mady OM, Hakim SA. Evaluation of the potential
prognostic value of tumor budding in laryngeal carcinoma by conventional
and immunohistochemical staining. Analytical Cellular Pathology.
2020;2020:1-12.
32. Jesinghaus M, Strehl J, Boxberg M, Brühl F, Wenzel A, Konukiewitz B,
et al. Introducing a novel highly prognostic grading scheme based on
tumour budding and cell nest size for squamous cell carcinoma of the
uterine cervix. The Journal of Pathology: Clinical Research.
2018;4(2):93-102.
33. Niwa Y, Yamada S, Koike M, Kanda M, Fujii T, Nakayama G, et al.
Epithelial to mesenchymal transition correlates with tumor budding and
predicts prognosis in esophageal squamous cell carcinoma. Journal of
surgical oncology. 2014;110(6):764-9.
34. Karjol U, Jonnada P, Annavarjula V, Cherukuru S, Chandranath A,
Anwar A, et al. Prognostic role of tumor budding in carcinoma tongue: a
systemic review and meta-analysis. Cureus. 2020;12(7).
35. Caruntu A, Moraru L, Lupu M, Ciubotaru DA, Dumitrescu M, Eftimie L,
et al. Assessment of Histological Features in Squamous Cell Carcinoma
Involving Head and Neck Skin and Mucosa. Journal of Clinical Medicine.
2021;10(11):2343.
36. D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, et al.
Elective versus therapeutic neck dissection in node-negative oral
cancer. New England Journal of Medicine. 2015;373(6):521-9.
37. Kirita T, Yamakawa N, Ueda N, Yagyuu T. Tumor budding as a useful
prognostic indicator in early oral squamous cell carcinoma. J Cancer Sci
Ther. 2018;10:162-7.
38. Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, et al.
Association of Quantitative Metastatic Lymph Node Burden With Survival
in Hypopharyngeal and Laryngeal Cancer. JAMA Oncol. 2018;4(7):985-9.
39. Imai T, Satoh I, Matsumoto K, Asada Y, Yamazaki T, Morita S, et al.
Retrospective observational study of occult cervical lymph-node
metastasis in T1N0 tongue cancer. Japanese journal of clinical oncology.
2017;47(2):130-6.
40. Imai T, Ito S, Oikawa T, Asada Y, Matsumoto K, Miyazaki T, et al.
Risk factors for cervical lymph node metastasis in endoscopically
resected superficial hypopharyngeal cancers. Auris Nasus Larynx.
2019;46(3):424-30.
41. Ebihara Y, Yoshida S, Nakahira M, Kogashiwa Y, Enoki Y, Kuba K, et
al. Importance of tumor budding grade as independent prognostic factor
for early tongue squamous cell carcinoma. Head & Neck.
2019;41(6):1809-15.
42. Li ZW, He L, Zheng Z, Zhang Q, Xu YT, Chen JY, et al. Combined
assessment of tumour cell nest size and desmoplastic reaction as an
excellent prognostic predictor in oesophageal squamous cell carcinoma.
Histopathology. 2022;80(7):1112-20.
43. Li J, Li X, Yang J. A Novel Prognostic Stratified System Based on
Tumor Budding and the Cell Nest Size in Ureter Urothelial Carcinoma.
Applied Bionics and Biomechanics. 2022;2022.
44. Gkegka AG, Koukourakis MI, Katotomichelakis M, Giatromanolaki A.
Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density
and Tertiary Lymphoid Structure Formation in Laryngeal Cancer. Head and
Neck Pathology. 2023;17(2):422-32.
45. Tan A, Taskin T. Tumor Budding Should Be in Oral Cavity Cancer
Reporting: A Retrospective Cohort Study Based on Tumor Microenvironment.
Cancers. 2023;15(15):3905.
46. Boxberg M, Jesinghaus M, Dorfner C, Mogler C, Drecoll E, Warth A, et
al. Tumour budding activity and cell nest size determine patient outcome
in oral squamous cell carcinoma: proposal for an adjusted grading
system. Histopathology. 2017;70(7):1125-37.
47. Sarioglu S, Acara C, Akman FC, Dag N, Ecevit C, Ikiz AO, et al.
Tumor budding as a prognostic marker in laryngeal carcinoma.
Pathology-Research and Practice. 2010;206(2):88-92.
48. Jesinghaus M, Brühl F, Steiger K, Klare P, Reiser M, Scheiter A, et
al. Cellular dissociation grading based on the parameters tumor budding
and cell nest size in pretherapeutic biopsy specimens allows for
prognostic patient stratification in esophageal squamous cell carcinoma
independent from clinical staging. The American journal of surgical
pathology. 2019;43(5):618-27.
49. Yadav K, Singh T, Varma K, Bhargava M, Misra V. Evaluation of tumor
budding and its correlation with histomorphological prognostic markers
in oral squamous cell carcinoma and its association with the
epithelial-mesenchymal transition process. Indian Journal of Pathology
and Microbiology. 2023;66(1):3.
50. Luo L, Liu H. High-grade tumor budding is a risk factor for survival
in patients with laryngeal squamous cell carcinoma. Brazilian Journal of
Otorhinolaryngology. 2023;89:101310.
51. Thomas B, Stedman M, Davies L. Grade as a prognostic factor in oral
squamous cell carcinoma: a population‐based analysis of the data. The
Laryngoscope. 2014;124(3):688-94.
52. Brandstorp-Boesen J, Sørum Falk R, Boysen M, Brøndbo K. Impact of
stage, management and recurrence on survival rates in laryngeal cancer.
PLoS One. 2017;12(7):e0179371.
Table 1. A summary of clinical and histopathological findings